A Global prospective observational study of Real-worlD managemEnt of patieNts with atrIal fibrillAtion at high risk of stroke (GARDENIA)

This type of research study is called a registry and is being done to learn more about immediate and long-term treatment and results in patients with Atrial Fibrillation, in order to determine best practices in the future.

Sponsor: Anthos Therapeutics, Inc.
IRB# 2022-143